Skip to main content

MelroseWakefield Hospital Achieves Zero Central Line Infection Rate

June 17, 2025

MelroseWakefield Hospital reports zero CLABSI cases, ranking among just ten in Massachusetts to achieve this top patient safety milestone, per CMS data.

MelroseWakefield Hospital is one of 339 hospitals across the United States and just one of ten in Massachusetts to record a central line associated bloodstream infection (CLABSI) rate of zero, according to the recently released Healthcare-Associated Infections dataset from Centers for Medicare & Medicaid Services.

CLABSI is a serious hospital-acquired infection that occurs when germs get into the bloodstream through a central line, or catheter which is placed into a patient's arm, neck, chest or groin to give them fluids or medications.

The Healthcare-Associated Infections dataset, updated April 30, includes performance data for five types of infections collected through the CDC's National Healthcare Safety Network. The measures show how often patients in a hospital contract infections during an inpatient stay compared to similar hospitals. The measures apply to all patients treated in acute care hospitals, including adult, pediatric, neonatal, Medicare and non-Medicare patients, according to the CMS data dictionary. Data was collected from July 2023 through June 2024.

"Our team at MelroseWakefield Hospital achieved a CLABSI rate of zero by implementing consistent safety protocols, training staff, and leading with a culture of safety and communication that always puts patient safety first," said Chief Medical Officer Michael DeLeo, MD.

We are proud to have achieved the zero infection rate and are committed to continuously providing the highest quality care.

Chief Medical Officer Michael DeLeo, MD

Healthy Podcast
Treating the Whole Patient - Dr. Anubha Bharthuar and Sue Appleyard
November 7, 2025
Cancer care is about more than just treating the disease - it's about supporting the person, families and loved ones behind the diagnosis.
Articles
Do You Need Lung Cancer Screening?
November 7, 2025
Tufts Medical Center thoracic surgeons, Lana Schumacher, MD and Miguel M. Leiva Juarez, MD, MSE share what you need to know about lung cancer risks, prevention and who should be screened.
David Hunt
Patient Stories
David’s Story: Ground-breaking Robotic Surgery + Immunotherapy for Esophageal Cancer
November 5, 2025
David Hunt of Woburn is a longtime EMT and community volunteer who has spent years on the front lines of the opioid crisis—teaching overdose response, hosting a television program on addiction and contributing to regional task forces focused on breaking the cycle of addiction and prevention. But in 2021, he found himself facing a personal health crisis: esophageal cancer.

Be among the first to know

Enjoy the latest health updates from Tufts Medicine by signing up for our e-newsletter today.

Jump back to top